相关实验视频

Updated: Apr 27, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

血管新素II型2受体用于控制疼痛

A H Jan Danser¹, Praveen Anand²

¹Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Rotterdam 3015 CN, The Netherlands.

|June 21, 2014

概括

血管新素II型2 (AT2) 受体

科学领域:

心血管科学心血管科学
内分泌学在内分泌学.
药理学药理学是指药理学的学科.

背景情况:

血管素II (Ang II) 的有害作用主要通过Ang II类型1 (AT1) 受体进行介导,导致AT1受体阻断剂 (ARB) 和心血管疾病的ACE抑制剂的发展.
尽管进行了广泛的研究,但Ang II型2 (AT2) 受体的确切功能仍然在很大程度上难以捉摸.
了解AT2受体的作用对于潜在地开发针对氨酸- ангиотензин系统的新治疗策略至关重要.

研究的目的:

阐明Ang II型2 (AT2) 受体在很大程度上未知的功能.
为正在进行的关于AT2受体在心血管生理和病理生理学中的作用的研究提供新的发现.
为了更深入地了解AT2受体的参与,超出了已知的AT1受体介导作用.

主要方法:

马里昂等人进行的研究. 介绍了对AT2受体功能的新见解.
马里昂等人使用的具体实验方法. 在完整的出版物中详细说明.
这项研究可能涉及体外和/或体内模型,以研究AT2受体信号通路.

主要成果:

马里昂等人进行的研究. 介绍了新的发现,进一步提高了我们对AT2受体的了解.
这些结果为AT2受体对生理或病理过程的贡献提供了新的视角.
具体的结果突出了与AT2受体激活相关的以前未知的作用或机制.

结论:

马里昂等人的研究. 为了解AT2受体增加了一个重要的新章节.
对AT2受体进行进一步的研究是有必要的,以充分理解其治疗潜力.
这些发现可能为在氨酸-血管新生素系统内的新型治疗标铺平了道路,这与AT1受体阻塞不同.

更多相关视频

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

相关概念视频

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...

Antihypertensive Drugs: Direct Renin Inhibitors

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...

Adrenergic Receptors: ɑ Subtype

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Hypertension II: Pathophysiology

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...